Delivery Order SPE2DB20D3303-SPE2DB24FZ6F6

Award Date 5/2/24
Potential Completion Date 5/3/24
Potential Value $7.2K
Ultimate Awardee
Cencora, Inc.
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
  • SPE2DB20D3303
    Indefinite Delivery Contract
  • SPE2DB20D3303-SPE2DB24FZ6F6
    Delivery Order

This is a Delivery Order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation. The contract is for the provision of PRADAXA 150 MG CAPSULE UU 60S, a pharmaceutical product, with a ceiling value of $7,228.14 and a completion date of May 3, 2024.

Amerisourcebergen Drug Corp is a major supplier of pharmaceutical products and medical supplies to the U.S. federal government, particularly the Department of Defense (DoD) and Veterans Affairs (VA) healthcare systems. The company leverages its parent company's extensive supply chain network to efficiently fulfill government contracts. This contract does not have a set-aside designation, indicating it was awarded on a full and open competition basis.

Amerisourcebergen Drug Corp also holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued up to $999,999,999.00 through December 31, 2025, which serves as the primary vehicle for the company to deliver a comprehensive range of pharmaceutical products and medical supplies to DLA facilities supporting the DoD worldwide.

Generated 8/1/24, 9:55 AM